Eric Neuhart

664 total citations
13 papers, 525 citations indexed

About

Eric Neuhart is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Eric Neuhart has authored 13 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Internal Medicine. Recurrent topics in Eric Neuhart's work include Venous Thromboembolism Diagnosis and Management (8 papers), Heparin-Induced Thrombocytopenia and Thrombosis (7 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Eric Neuhart is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (8 papers), Heparin-Induced Thrombocytopenia and Thrombosis (7 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Eric Neuhart collaborates with scholars based in France, United States and Switzerland. Eric Neuhart's co-authors include Jean‐François Bergmann, Paul Gallo, John J.V. McMurray, Frans Van de Werf, Aldo P. Maggioni, Jean‐Lucien Rouleau, Eric J. Velazquez, Mary Ann Sellers, Robert M. Califf and Susan Edwards and has published in prestigious journals such as Hypertension, American Heart Journal and Thrombosis and Haemostasis.

In The Last Decade

Eric Neuhart

13 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Neuhart France 7 426 285 128 55 50 13 525
J.J.C. Jonker Netherlands 12 473 1.1× 309 1.1× 156 1.2× 50 0.9× 50 1.0× 22 666
Sergio Cannizzaro Italy 13 411 1.0× 117 0.4× 70 0.5× 69 1.3× 64 1.3× 31 519
B Krähenbühl Switzerland 10 129 0.3× 166 0.6× 140 1.1× 43 0.8× 59 1.2× 37 362
Franck Barbou France 7 376 0.9× 136 0.5× 201 1.6× 29 0.5× 83 1.7× 21 458
J S Ginsberg Canada 7 391 0.9× 454 1.6× 143 1.1× 12 0.2× 20 0.4× 9 594
Valentina Mera Italy 9 327 0.8× 381 1.3× 128 1.0× 10 0.2× 61 1.2× 11 538
M Benhamou France 5 305 0.7× 167 0.6× 147 1.1× 13 0.2× 87 1.7× 12 417
Koon-Hou Mak United States 8 360 0.8× 144 0.5× 287 2.2× 20 0.4× 25 0.5× 11 487
Sergio Dalla‐Volta Italy 12 622 1.5× 236 0.8× 136 1.1× 14 0.3× 91 1.8× 34 769
Justin Levisay United States 9 617 1.4× 171 0.6× 349 2.7× 81 1.5× 49 1.0× 21 671

Countries citing papers authored by Eric Neuhart

Since Specialization
Citations

This map shows the geographic impact of Eric Neuhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Neuhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Neuhart more than expected).

Fields of papers citing papers by Eric Neuhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Neuhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Neuhart. The network helps show where Eric Neuhart may publish in the future.

Co-authorship network of co-authors of Eric Neuhart

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Neuhart. A scholar is included among the top collaborators of Eric Neuhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Neuhart. Eric Neuhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Guéret, Pierre, S. Combe, Eliane Fuseau, et al.. (2016). Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study. European Journal of Clinical Pharmacology. 73(1). 15–28. 3 indexed citations
2.
Guéret, Pierre, S. Combe, Eliane Fuseau, et al.. (2016). First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action. European Journal of Clinical Pharmacology. 72(9). 1041–1050. 4 indexed citations
3.
Guéret, Pierre, et al.. (2013). EP42675, a synthetic parenteral dual‐action anticoagulant: pharmacokinetics, pharmacodynamics, and absence of interactions with antiplatelet drugs. Journal of Thrombosis and Haemostasis. 12(1). 24–33. 2 indexed citations
4.
Raaz, Uwe, Alexander Vogt, Eric Neuhart, et al.. (2013). In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated heparin, enoxaparin, and fondaparinux in preventing cardiac catheter thrombosis. Journal of Thrombosis and Thrombolysis. 37(2). 118–130. 6 indexed citations
5.
Vogt, Liffert, Carlos Chiurchiu, Harbajan Chadha‐Boreham, et al.. (2010). Effect of the Urotensin Receptor Antagonist Palosuran in Hypertensive Patients With Type 2 Diabetic Nephropathy. Hypertension. 55(5). 1206–1209. 31 indexed citations
6.
Cotter, Gad, Edo Kaluski, Karl Stangl, et al.. (2004). The Hemodynamic and Neurohormonal Effects of Low Doses of Tezosentan (An Endothelin A/B Receptor Antagonist) in Patients with Acute Heart Failure. European Journal of Heart Failure. 6(5). 601–609. 51 indexed citations
7.
Pfeffer, Marc A., John J.V. McMurray, Alain Leizorovicz, et al.. (2000). Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design. American Heart Journal. 140(5). 727–750. 139 indexed citations
8.
9.
Bergmann, Jean‐François & Eric Neuhart. (1996). A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.. PubMed. 76(4). 529–34. 135 indexed citations
10.
Soria, J., et al.. (1992). Effect of heparin and enoxaparin on platelet interaction with fibrin clots. Thrombosis Research. 65(2). 187–191. 13 indexed citations
11.
Faivre, René, Eric Neuhart, Massoud Mirshahi, et al.. (1989). Fibrinolytic and Thrombolytic Parameters in Patients with Deep Vein Thrombosis Treated by Low Molecular Weight and Standard Heparin. Seminars in Thrombosis and Hemostasis. 15(4). 435–439. 5 indexed citations
12.
Neuhart, Eric, et al.. (1987). [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].. PubMed. 12 Suppl B. 145–6. 4 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.J.C. Jonker Breakdown of academic impact, for papers by Sergio Cannizzaro Breakdown of academic impact, for papers by B Krähenbühl Breakdown of academic impact, for papers by Franck Barbou Breakdown of academic impact, for papers by J S Ginsberg Breakdown of academic impact, for papers by Valentina Mera Breakdown of academic impact, for papers by M Benhamou Breakdown of academic impact, for papers by Koon-Hou Mak Breakdown of academic impact, for papers by Sergio Dalla‐Volta Breakdown of academic impact, for papers by Justin Levisay
Rankless by CCL
2026